BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30575764)

  • 1. CHA
    Yi JE; Lee YS; Choi EK; Cha MJ; Kim TH; Park JK; Lee JM; Kang KW; Shim J; Uhm JS; Kim J; Kim C; Kim JB; Park HW; Joung B; Park J
    Sci Rep; 2018 Dec; 8(1):18039. PubMed ID: 30575764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHADS2 and CHA2DS2-VASc scores are independently associated with incident atrial fibrillation: the Catanzaro Atrial Fibrillation Project.
    Sciacqua A; Perticone M; Tripepi G; Tassone EJ; Cimellaro A; Mazzaferro D; Sesti G; Perticone F
    Intern Emerg Med; 2015 Oct; 10(7):815-21. PubMed ID: 25939338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
    Saliba W; Rennert G
    Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHA
    Rapacciuolo A; Mancusi C; Canciello G; Izzo R; Strisciuglio T; de Luca N; Ammirati G; de Simone G; Trimarco B; Losi MA
    Sci Rep; 2019 May; 9(1):7888. PubMed ID: 31133712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
    Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
    Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relation Between Echocardiographic Epicardial Fat Thickness and CHA2DS2-VASc Score in Patients with Sinus Rhythm.
    Aksoy F; Guler S; Kahraman F; Oskay T; Varol E
    Braz J Cardiovasc Surg; 2019; 34(1):41-47. PubMed ID: 30810673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.
    Lau KK; Chan PH; Yiu KH; Chan YH; Liu S; Chan KH; Yeung CY; Li SW; Tse HF; Siu CW
    Cardiol J; 2014; 21(5):474-83. PubMed ID: 24846512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHA
    Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
    Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Value of the CHADS
    Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA
    Østergaard L; Olesen JB; Petersen JK; Nielsen LS; Kristensen SL; Schou M; Køber L; Fosbøl E
    Circulation; 2024 Mar; 149(10):764-773. PubMed ID: 38152890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The co-predictive value of a cardiovascular score for CV outcomes in diabetic patients with no atrial fibrillation.
    Patti G; Sticchi A; Pasceri V; Ricci F; Renda G; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3145. PubMed ID: 30790434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel composite scoring system to predict unknown atrial fibrillation in acute ischemic stroke patients.
    Liu R; Yang X; Li S; Jiang Y; Wang Y; Wang Y
    Brain Res; 2017 Nov; 1674():36-41. PubMed ID: 28823956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA
    Lee JM; Kim JB; Uhm JS; Pak HN; Lee MH; Joung B
    Heart Rhythm; 2017 Sep; 14(9):1297-1301. PubMed ID: 28559088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CHA
    Hu WS; Lin CL
    BMJ Open; 2018 Mar; 8(3):e020065. PubMed ID: 29567851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.